KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 293 filers reported holding KARUNA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,350,818 | -22.1% | 203,151 | -0.1% | 0.02% | -19.0% |
| Q2 2023 | $44,092,165 | +23.5% | 203,330 | +3.5% | 0.02% | +16.7% |
| Q1 2023 | $35,700,423 | -7.5% | 196,545 | +0.0% | 0.02% | -10.0% |
| Q4 2022 | $38,612,250 | -12.8% | 196,500 | -0.2% | 0.02% | -16.7% |
| Q3 2022 | $44,291,000 | +39.9% | 196,912 | -21.3% | 0.02% | +50.0% |
| Q2 2022 | $31,662,000 | +9.7% | 250,279 | +9.9% | 0.02% | +33.3% |
| Q1 2022 | $28,865,000 | +3.2% | 227,664 | +6.6% | 0.01% | +20.0% |
| Q4 2021 | $27,969,000 | +9.6% | 213,500 | +2.3% | 0.01% | 0.0% |
| Q3 2021 | $25,530,000 | +7.7% | 208,700 | +0.4% | 0.01% | +11.1% |
| Q2 2021 | $23,698,000 | -1.4% | 207,900 | +4.0% | 0.01% | -10.0% |
| Q1 2021 | $24,034,000 | – | 199,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 908,708 | $109,254,000 | 35.05% |
| Sofinnova Investments, Inc. | 1,952,441 | $234,742,000 | 14.11% |
| Logos Global Management LP | 200,000 | $24,046,000 | 2.35% |
| First Light Asset Management, LLC | 258,500 | $31,079,000 | 2.06% |
| Eventide Asset Management | 971,077 | $116,753,000 | 1.73% |
| DAFNA Capital Management LLC | 48,000 | $5,771,000 | 1.37% |
| CATALYST PRIVATE WEALTH, LLC | 13,006 | $1,564,000 | 1.10% |
| Rock Springs Capital Management LP | 368,764 | $44,336,000 | 0.97% |
| Pinz Capital Management, LP | 28,805 | $3,463,000 | 0.92% |
| MILLER VALUE PARTNERS, LLC | 291,239 | $35,016,000 | 0.91% |